In Vitro Susceptibilities of Madurella mycetomatis to Itraconazole and Amphotericin B Assessed by a Modified NCCLS Method and a Viability-Based 2,3-Bis(2-Methoxy-4-Nitro-5- Sulfophenyl)-5-[(Phenylamino)Carbonyl]-2 H - Tetrazolium Hydroxide (XTT) Assay

Abdalla O. A. Ahmed(University of Khartoum), Irma A. J. M. Bakker‐Woudenberg(Erasmus MC), Alex van Belkum(Rijnstate Hospital), Wim van Vianen(Erasmus MC), Henri A. Verbrugh(Medisch Centrum Haaglanden), Wendy W. J. van de Sande(Erasmus MC), Ahmed Hassan Fahal(African Field Epidemiology Network)

Antimicrobial Agents and Chemotherapy

June 23, 2004

Cited by 82

|The Lancet Infectious Diseases|2015|343

|Transactions of the Royal Society of Tropical Medicine and Hygiene|2003|307

|The Lancet Infectious Diseases|2017|294

|The Lancet Infectious Diseases|2004|269

|PLoS neglected tropical diseases|2017|191

In Vitro Susceptibilities of <i>Madurella mycetomatis</i> to Itraconazole and Amphotericin B Assessed by a Modified NCCLS Method and a Viability-Based 2,3-Bis(2-Methoxy-4-Nitro-5- Sulfophenyl)-5-[(Phenylamino)Carbonyl]-2 <i>H</i> - Tetrazolium Hydroxide (XTT) Assay